학술논문
A phase 3, randomized, double-blind, clinical study to evaluate the long-term safety and efficacy of gefapixant in Japanese adult participants with refractory or unexplained chronic cough
Document Type
Article
Author
Source
In: Allergology International . (Allergology International, October 2022, 71(4):498-504)
Subject
Language
English
ISSN
14401592
13238930
13238930